TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

Daily Oral Ibandronate With Adjuvant Endocrine Therapy in Postmenopausal Women With Estrogen Receptor-Positive Breast Cancer (BOOG 2006-04): Randomized Phase III TEAM-IIB Trial.

Sonja B Vliek et al.PubMed ↗Publisher ↗

No numbers read from the abstract.